These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34464233)

  • 1. Clinical Relevance of Autoantibodies and Inflammatory Parameters in Non-infectious Scleritis.
    Vergouwen DPC; Ten Berge JC; Boukhrissi S; Rothova A; Schreurs MWJ
    Ocul Immunol Inflamm; 2022; 30(7-8):1859-1865. PubMed ID: 34464233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of ophthalmological and serological manifestations and the therapeutic response of patients with isolated scleritis and scleritis associated with systemic diseases.
    Sousa JM; Trevisani VF; Modolo RP; Gabriel LA; Vieira LA; Freitas Dd
    Arq Bras Oftalmol; 2011; 74(6):405-9. PubMed ID: 22331111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis.
    Lin P; Bhullar SS; Tessler HH; Goldstein DA
    Am J Ophthalmol; 2008 Mar; 145(3):463-471. PubMed ID: 18061135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
    Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
    Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel technique of full-thickness scleral debridement in fulminant necrotising infectious scleritis and its outcomes-a consecutive case series.
    Karkhur S; Soni D; Sharma B
    Int Ophthalmol; 2022 Feb; 42(2):581-592. PubMed ID: 34613564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
    Shi J; Knevel R; Suwannalai P; van der Linden MP; Janssen GM; van Veelen PA; Levarht NE; van der Helm-van Mil AH; Cerami A; Huizinga TW; Toes RE; Trouw LA
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17372-7. PubMed ID: 21987802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.
    Meyer P; Ally M; Hodkinson B; Anderson R; Tikly M
    Afr Health Sci; 2018 Jun; 18(2):295-303. PubMed ID: 30602956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
    Katsumata M; Hozumi H; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2019; 154():102-108. PubMed ID: 31229943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Ahn SS; Pyo JY; Song JJ; Park YB; Lee SW
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454396
    [No Abstract]   [Full Text] [Related]  

  • 10. [Autoantibody pattern in scleritis and episcleritis].
    Zierhut M; Denk PO; Klein R; Berg PA; Erb C; Thiel HJ
    Ophthalmologe; 1997 Feb; 94(2):157-60. PubMed ID: 9156642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
    Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
    Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year outcome in immune-mediated scleritis.
    Bernauer W; Pleisch B; Brunner M
    Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1477-81. PubMed ID: 25007956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CCP antibodies: the past, the present and the future.
    van Venrooij WJ; van Beers JJ; Pruijn GJ
    Nat Rev Rheumatol; 2011 Jun; 7(7):391-8. PubMed ID: 21647203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.
    Lloyd KA; Wigerblad G; Sahlström P; Garimella MG; Chemin K; Steen J; Titcombe PJ; Marklein B; Zhou D; Stålesen R; Ossipova E; Lundqvist C; Ekwall O; Rönnelid J; Mueller DL; Karlsson MCI; Kaplan MJ; Skriner K; Klareskog L; Wermeling F; Malmström V; Grönwall C
    Front Immunol; 2018; 9():3033. PubMed ID: 30662440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
    Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
    Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis.
    Soukiasian SH; Foster CS; Niles JL; Raizman MB
    Ophthalmology; 1992 Jan; 99(1):125-32. PubMed ID: 1741124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleritis: a clinicopathologic study of 55 cases.
    Riono WP; Hidayat AA; Rao NA
    Ophthalmology; 1999 Jul; 106(7):1328-33. PubMed ID: 10406616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis).
    Yoshida A; Watanabe M; Okubo A; Kawashima H
    Jpn J Ophthalmol; 2019 Sep; 63(5):417-424. PubMed ID: 31183624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis.
    Itty S; Pulido JS; Bakri SJ; Baratz KH; Matteson EL; Hodge DO
    Trans Am Ophthalmol Soc; 2008; 106():75-81; discussion 81-3. PubMed ID: 19277223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.
    Ossipova E; Cerqueira CF; Reed E; Kharlamova N; Israelsson L; Holmdahl R; Nandakumar KS; Engström M; Harre U; Schett G; Catrina AI; Malmström V; Sommarin Y; Klareskog L; Jakobsson PJ; Lundberg K
    Arthritis Res Ther; 2014 Aug; 16(4):R167. PubMed ID: 25112157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.